OR YAT SUN,MA JUN,WANG GUOQIANG,LONG JIANG,WANG BIN
申请号：
IN2891/DELNP/2013
公开号：
IN2013DN02891A
申请日:
2013.04.02
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention discloses compounds of Formula (I) or pharmaceutically acceptable salts esters or prodrugs thereof: Formula (I) which inhibit serine protease activity particularly the activity of hepatitis C virus (HCV) NS3 NS4A protease. Consequently the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
